The rising Organ-on-Chip Market Demand can be attributed to government initiatives aimed at reducing animal testing, as well as advancements in biofabrication technologies. The increasing acceptance of organ-on-chip technology by pharmaceutical and biotechnology companies is further contributing to market growth. However, technical complexities and low throughput are challenges that could limit expansion. The report " Organ-On-Chip... Continue Reading →